A previous report has revealed that the melanoma cell-intrinsic Wnt/β-catenin signaling activation is associated with the nonexistence of a T-cell gene expression signature, rendering the resistance to anti-PD-L1/anti-CTLA-4 monoclonal antibody treatment [46]. The gene discussed is CTLA4; the disease is melanoma.